Study on bioequivalence of famciclovir capsules in human
Ke Li
Abstract
Ke Li
Abstract
OBJECTIVE To study the pharmacokinetics and the relative bioavailability of famciclovir capsule.METHODS 12 healthy male volunteers were enrolled.Plasma concentrations of penciclovir were determined by HPLC with fluorescence detection following administration of the oral prodrug,famciclovir.RESULTS The pharmacokinetic parameters of famciclovir capsule and tablet were as follow: t max (0.774±0.190) and (0.748±0.181) h; c max (4.207±1.079) and (4.303±1.271) mg·L -1 ; AUC 0~∞ (15.476±3.654) and (14.828±3.420) mg·h·L -1 ,and AUC 0~t (14.622±3.605) and (14.072±3.459) mg·h·L -1 ,respectively.The relative bioavailability of famciclovir capsule was (104.5±10.2)%.CONCLUSION The test capsule and reference tablet of famciclovir were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics and the relative bioavailability of famciclovir capsule.METHODS 12 healthy male volunteers were enrolled.Plasma concentrations of penciclovir were determined by HPLC with fluorescence detection following administration of the oral prodrug,famciclovir.RESULTS The pharmacokinetic parameters of famciclovir capsule and tablet were as follow: t max (0.774±0.190) and (0.748±0.181) h; c max (4.207±1.079) and (4.303±1.271) mg·L -1 ; AUC 0~∞ (15.476±3.654) and (14.828±3.420) mg·h·L -1 ,and AUC 0~t (14.622±3.605) and (14.072±3.459) mg·h·L -1 ,respectively.The relative bioavailability of famciclovir capsule was (104.5±10.2)%.CONCLUSION The test capsule and reference tablet of famciclovir were bioequivalent.
Key concepts: Famciclovir, Penciclovir, Bioequivalence, Capsule, Pharmacokinetics, Bioavailability, Prodrug, Medicine